Gestational choriocarcinoma whose responsible pregnancy was a complete hydatidiform mole identified by PCR analysis with new sequence tagged site primers

Japanese Journal of Clinical Oncology

Volumn 29, Issue 10, 1999, Pages 504-508

  Kaneta, Yoshibumi ^a,c   Yoshiyama, Reiko ^a   Inagaki, Noboru ^a   Toyoshima, Kiwamu ^a   Ito, Kimihiko ^a   Nishino, Ruriko ^a   Kitai, Hirokatsu ^a   Kato, Hidenori ^b   Asanoma, Kazuo ^b   Wake, Norio ^b  

^a Saitama Shakaihoken Hospital   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c Saitamachuou Hospital   (Japan)

Author keywords

Choriocarcinoma; Polymerase chain reaction (PCR); Sequence tagged site (STS) primer

Indexed keywords

PRIMER DNA;

ARTICLE; CHORIOCARCINOMA; FEMALE; GENETICS; HUMAN; HYDATIDIFORM MOLE; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY COMPLICATION; SEQUENCE TAGGED SITE; UTERUS CANCER;

CHORIOCARCINOMA; DNA PRIMERS; FEMALE; HUMANS; HYDATIDIFORM MOLE; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; SEQUENCE TAGGED SITES; UTERINE NEOPLASMS;

EID: 0033202453     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/29.10.504     Document Type: Article

References (13)

1. Hara T, Kaseki S, Tomoda Y, Nishikawa Y, Ishizuka T, Ishizuka N. Determinants of risk for developing invasive mole and choriocarcinoma following hydatidiform mole. Asia-Oceania J Obstet Gynecol 1986;12:241-50.
2. Fisher RA, Lawler SD, Povey S, Bagshawe KD. Genetically homozygous choriocarcinoma following pregnancy with hydatidiform mole. Br J Cancer 1988;58:788-92.
3. Chaganti RSK, Koduru PRK, Chakraborty R, Jones WB. Genetic origin of a trophoblastic choriocarcinoma. Cancer Res 1990;50:6330-3.
4. Azuma C, Saji F, Nobunaga T, Kamiura S, Kimura T, Tokugawa Y, et al. Studies on the pathogenesis of choriocarcinoma by analysis of restriction fragment length polymorphisms. Cancer Res 1990;50:488-91.
5. Osada H, Kawata M, Yamada M, Okumura K, Takamizawa H. Genetic identification of pregnancies responsible for choriocarcinomas after multiple pregnancies by restriction fragment length polymorphism analysis. Am J Obstet Gynecol 1991;165:682-8.
6. Fisher RA, Newlands ES, Jeffreys AJ, Boxer GM, Begent RHJ, Rustin GJS, et al. Gestational and nongestational trophoblastic tumors distinguished by DNA analysis. Cancer 1992;69:839-45.
7. Suzuki T, Goto S, Nawa A, Kurauchi O, Saito M, Tomoda Y. Identification of the pregnancy responsible for gestational trophoblastic disease by DNA analysis. Obstet Gynecol 1993;82:629-34.
8. Arima T, Imamura T, Amada S, Tsuneyoshi M, Wake N. Genetic origin of malignant trophoblastic neoplasms. Cancer Genet Cytogenet 1994:73:95-102.
9. Arima T, Imamura T, Sakuragi N, Higashi M, Kamura T, Fujimoto S, et al. Malignant trophoblastic neoplasms with different modes of origin. Cancer Genet Cytogenet 1995;85:5-15.
10. Maehara T, Uemura S, Higashi M, Kanazawa K, Unten K. A case of primary gestational ovarian choriocarcinoma. Nippon Sanka Fujinka Gakkai Zasshi 1996;48:427-30 (in Japanese).
11. Vojtassak J, Repiska V, Zajac V, Konecna B, Korbel M, Danihel L. Origin of choriocarcinoma in previous molar pregnancy proved by DNA analysis. Neoplasia 1996;43:57-9.
12. Japan Society of Obstetrics and Gynecology and the Japanese Pathological Society. The General Rules for Clinical and Pathological Management of Trophoblastic Disease, 2nd ed. Tokyo: Kanehara 1995;8-23.
13. FIGO Annu Rep Results Treat Gynecol Cancer 1991;21:310.